Ropivacaine

- TRADE NAME: Naropin (AstraZeneca)
- INDICATIONS: Surgical anesthesia, acute pain management
- CLASS: Anesthetic; local
- HALF-LIFE: 1.1–2.5 hours after intravascular administration; 3.2–5.2 hours after epidural administration
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adenosine, Aminophylline, Amiodarone, Ciprofloxacin, Dronedarone, Fluvoxamine, Imipramine, Ketoconazole
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OTIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric